3.88 0.00 (0.00%)
After hours: 5:00PM EST
|Bid||3.88 x 800|
|Ask||4.01 x 4000|
|Day's Range||3.7950 - 4.0500|
|52 Week Range||3.1700 - 6.1500|
|Beta (3Y Monthly)||1.79|
|PE Ratio (TTM)||N/A|
|Earnings Date||Jan 22, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||5.97|
Accuray (ARAY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SUNNYVALE, Calif., Jan. 8, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report results for its second quarter ended December 31, 2018 on Tuesday, January 22, 2019 after the market close. ...
We often see insiders buying up shares in companies that perform well over the long term. On the other hand, we'd be remiss not to mention that insider sales have Read More...
SUNNYVALE, Calif. , Jan. 2, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the Company will present at the J.P. Morgan 37th Annual Healthcare Conference on Wednesday, January ...
The government requires hedge funds and wealthy investors with over a certain portfolio size to file a report that shows their positions at the end of every quarter. Even though it isn’t the intention, these filings level the playing field for ordinary investors. The latest round of 13F filings disclosed the funds’ positions on September […]
SUNNYVALE, Calif., Dec. 6, 2018 /PRNewswire/ -- Accuray Incorporated (ARAY) announced today that the new release of its Accuray Precision® Treatment Planning System (TPS) with the CyberKnife® VOLO™ Optimizer will enable CyberKnife System customers to significantly improve operational efficiency by reducing both the time to create high quality treatment plans and the time it takes to deliver patient treatments.
Joshua Levine became the CEO of Accuray Incorporated (NASDAQ:ARAY) in 2012. This analysis aims first to contrast CEO compensation with other companies that have similar market capitalization. Next, we'll consider Read More...
Accuray's (ARAY) benefits from growing adoption of non-surgical treatment options among cancer patients and increasing demand for its latest offerings.
SUNNYVALE, Calif., Nov. 19, 2018 /PRNewswire/ -- Accuray Incorporated (ARAY) announced today that its Board of Directors has named Shig Hamamatsu as senior vice president, chief financial officer effective immediately. Mr. Hamamatsu joined Accuray as its vice president of finance and chief accounting officer in September 2017 before assuming the role of interim chief financial officer on October 1, 2018. "Shig has a proven track record of more than 15 years building and leading public company global finance organizations that drive results," said Joshua H. Levine, president and chief executive officer.
NEW YORK, Nov. 12, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
President & CEO of Accuray Inc (NASDAQ:ARAY) Joshua Levine bought 25,000 shares of ARAY on 11/05/2018 at an average price of $4.75 a share.
Accuray (ARAY) delivered earnings and revenue surprises of -16.67% and 0.77%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
On a per-share basis, the Sunnyvale, California-based company said it had a loss of 11 cents. Losses, adjusted for asset impairment costs, were 7 cents per share. The radiation oncology company posted ...
SUNNYVALE, Calif. , Oct. 30, 2018 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported its financial results for the first quarter of fiscal 2019 ended September 30, 2018 . Company Highlights ...
The big shareholder groups in Accuray Incorporated (NASDAQ:ARAY) have power over the company. Insiders often own a large chunk of younger, smaller, companies while huge companies tend to have institutions Read More...
SUNNYVALE, Calif. , Oct. 17, 2018 /PRNewswire/ -- Building on its heritage of patient-first innovation, at this year's ASTRO (American Society for Radiation Oncology) Annual Meeting, Accuray Incorporated ...
SUNNYVALE, Calif. , Oct. 11, 2018 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report results for its first quarter ended September 30, 2018 on Tuesday, October 30, 2018 after the market close. ...
SUNNYVALE, Calif., Oct. 9, 2018 /PRNewswire/ -- Accuray Incorporated (ARAY) announced today that the Klinikum rechts der Isar der Technischen Universität München (TUM) clinical team has treated the first cancer patients in Germany with the innovative Radixact® System. This next-generation helical radiation therapy technology replaced an existing, earlier generation TomoTherapy® System at TUM, reinforcing its value to the hospital as a workhorse radiation therapy device capable of treating a wide range of indications from simple to complex.